Oscar Health Inc. (NYSE: OSCR) reported Q1 EPS of ($0.18), $0.12 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.27 billion.

Oscar is reaffirming its full year 2023 outlook across all metrics as provided in its financial results press release dated February 9, 2023, including anticipated MLR range between 82% and 84%, and Adjusted EBITDA1 loss of ($175) million to ($75) million.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.